Joel Nowak, a man living with prostate cancer and the co-founder and CEO of Cancer ABCs discusses the importance of making clinical data (like the recent patient-focused publication in “Future Oncology” Online Feb 2021) available to patients and caregivers to promote informed decision-making and empower men to take charge of their health. As the co-founder and CEO of Cancer ABCs, he has a unique perspective on patient advocacy and the value of bringing resources to men living with prostate cancer. He was also uniquely involved in the publication of the patient-focused research that was published in Future Oncology.
Andria Aird, Pharmacist-owner at Blooms The Chemist Port Coogee and Blooms The Chemist Joondalup, talks to Health Professional Radio about the impact of sleep deprivation and sleep apnoea on Australians ahead of World Sleep Day (March 19th).
Alarming statistics about the physical and mental impact of poor sleep are on the agenda this World Sleep Day as Australia’s leading community pharmacy group, Blooms The Chemist, aims for a national Wakeup Call record, shining the spotlight on the dangers of leaving sleep issues such as sleep apnoea unchecked. According to The Sleep Health Foundation (2021), sleep issues are on the rise following high levels of disruption to our lives brought on by the change in lifestyle patterns due to COVID-19.Poor sleep hygiene affects our immunity which is vitally important during this time.
Take the online sleep quiz here
Dr. Janelle Sabo, Global Therapeutics Platform Leader at Eli Lilly & Company discusses COVID-19 monoclonal antibody treatments and how if given within 10 days of symptoms appearing can decrease the risk of hospitalization and/or disease progression in appropriate patients and having a plan of action should a high-risk individual test positive.
Jamie Milas, Vice President of Marketing at Medical Microinstruments S.p.A. (MMI), an Italian startup robotics company, discusses their robotic system for microsurgery. Combining proprietary innovations including the world’s smallest wristed microinstruments as well as tremor-reducing and motion-scaling technologies, MMI’s Symani® Surgical System enables surgeons to scale down movement to enhance microsurgical procedures while expanding the field of supermicrosurgery.
Marie E. Lamont, President and Chief Operating Officer at Inteliquet™, a leader in clinical trial matching, discusses the impact COVID has had on clinical trials and how companies have leveraged advanced technology tools to further research, improve patient recruitment, and use AI and Machine Learning to recognize behaviors and patterns to constantly improve on the data collection process overall.
Returning guest, Dr. Neal Shore, MD, FACS, Medical Director for the Carolina Urologic Research Center discusses the importance of patient-centric treatment decision-making and the publication of an easy-to-understand summary of important clinical trial data in “Future Oncology“, a leading medical journal (Online Feb 2021).
Josh Swider, CEO of Infinite Chemical Analysis Labs discusses the anticipated expansion of the hemp and cannabis industries and the new guidelines to regulate the same. He talks about a trend called “lab shopping” where cultivators are taking samples of their product to multiple labs with questionable practices to obtain the highest potency results and how this is creating an uneven playing field for labs that are operating in compliance.
Gyula Kangiszer, President, RotChrom Technologies North America, developers of the first industrial-scale Centrifugal Partition Chromatography (CPC) technology platform, discusses the partnership with Cyclolab Cyclodextrin Research and Development Laboratory Ltd. (“Cyclolab”) aimed at developing a more efficient and cost-effective process to purify Remdesivir, a direct-acting antiviral agent approved in countries around the world to treat patients with severe cases of COVID-19.Bio
Mary Lou Ballweg, President and Executive Director of the Endometriosis Association and founder of Endometriosis Awareness Month in March discusses the endometriosis diagnosis journey, the mission behind the Alliance for Endometriosis. and the importance of encouraging open and productive conversations about endometriosis
Jakob Dahlberg, CEO and co-founder at Joint Academy discusses a research study published in “JAMA Network Open” (Feb 23, 2021) that found clinically important improvements of treating knee osteoarthritis digitally rather than the traditional treatment, making it a superior treatment option with the potential to save insurance companies and their patients the costs and risks of joint surgeries.